Prognostic impact of CD34 and SMA in cancer‐associated fibroblasts in stage I–III NSCLC

Prognostic impact of CD34 and SMA in cancer‐associated fibroblasts in stage I–III NSCLC

Abstract Background Epithelial‐to‐mesenchymal transition (EMT) is a crucial step in lung cancer pathogenesis. Among others, cancer‐associated fibroblasts (CAFs) are reported to regulate this process. Objectives To investigate the prognostic and clinical impact, we analyzed CD34+ and SMA+ CAFs in non...

Full description

Bibliographic Details
Main Authors: Arik Bernard Schulze, Lars Henning Schmidt, Birthe Heitkötter, Sebastian Huss, Michael Mohr, Alessandro Marra, Ludger Hillejan, Dennis Görlich, Peter J. Barth, Jan Rehkämper, Georg Evers
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Thoracic Cancer
Subjects:
Cancer associated fibroblast
CD34
EMT
NSCLC
SMA
Online Access:https://doi.org/10.1111/1759-7714.13248

Internet

https://doi.org/10.1111/1759-7714.13248

Similar Items